Table 2.
Prescription distribution by drug groups and days’ supply establishing methods, for the full dataset (2012-2019).
| Drug group and dataset information | Method for finding days, supply | Prescriptions in main group, n (%) | |||
| Tablets, capsules, and suppositories | |||||
|
|
Daily dose provided | Calculated using the given daily dose | 2,828,617 (45.80) | ||
|
|
Days’ supply provided | Days’ supply was used | 933,710 (15.12) | ||
|
|
Neither daily dose nor days’ supply provided | Calculated using the imputed daily dose value | 2,402,392 (38.89) | ||
|
|
Days’ supply could neither be calculated nor imputed | —a | 11,866 (0.19) | ||
| Semisolid dosage forms | |||||
|
|
Days’ supply provided | Days’ supply was used | 119,748 (37.55) | ||
|
|
Days’ supply not provided | Imputed as 30 days per packageb | 199,154 (62.45) | ||
| Medicinal nail polish | |||||
|
|
Days’ supply provided | Days’ supply was used | 3008 (41.55) | ||
|
|
Days’ supply not provided | Imputed as 210 days or 180 daysb | 4231 (58.45) | ||
| Ear drops | |||||
|
|
Days’ supply provided | Days’ supply was used | 5661 (57.11) | ||
|
|
Days’ supply not provided | Imputed as 7 days per prescriptionb | 4252 (42.89) | ||
| Eye drops | |||||
|
|
Eye drops in single-dose containers - daily dose provided | Calculated using the given daily dose | 6724 (2.35) | ||
|
|
Other eye drops - days’ supply provided | Days’ supply was used | 62,332 (21.81) | ||
|
|
Other eye drops - days’ supply not provided | Imputed as 14b or 30c days per package | 216,740 (75.82) | ||
|
|
Days’ supply not calculated nor imputed | — | 43 (0.02) | ||
| Oral drops | |||||
|
|
Daily dose provided | Calculated using the given daily dose | 52,085 (53.03) | ||
|
|
Days’ supply provided | Days’ supply was used | 33,055 (33.65) | ||
|
|
Neither daily dose nor days’ supply provided | Imputed as 30 days per prescriptionb | 12,961 (13.20) | ||
|
|
Days’ supply neither calculated nor imputed | — | 120 (0.12) | ||
| Inhalation medication | |||||
|
|
Daily dose provided | Calculated using the given daily dose | 78,541 (62.04) | ||
|
|
Days’ supply provided | Days’ supply was used | 19,885 (15.71) | ||
|
|
Days’ supply not provided | Imputed as 60 days per prescriptionb | 27,137 (21.44) | ||
|
|
Days’ supply not calculated nor imputed | — | 1025 (0.81) | ||
| Nasal sprays | |||||
|
|
Antifungal nasal spray - days’ supply not provided | Imputed as 7 days per prescriptionb | 7738 (8.72) | ||
|
|
Daily dose provided | Calculated using the given daily dose | 26,361 (29.70) | ||
|
|
Days’ supply provided | Days’ supply was used | 40,551 (45.69) | ||
|
|
Neither daily dose nor days’ supply provided | Imputed as 30 days per prescriptionb | 14,094 (15.88) | ||
| Syrups | |||||
|
|
Antibiotics - days’ supply not provided | Imputed as 14 days per prescriptionb | 29,130 (34.31) | ||
|
|
Daily dose provided | Calculated using the given daily dose | 37,251 (43.87) | ||
|
|
Days’ supply provided | Days’ supply was used | 3094 (3.64) | ||
|
|
Days’ supply not provided | Imputed as 30 days per packagec | 15,436 (18.18) | ||
| Transdermal patch | |||||
|
|
Hormonal patch - days’ supply not provided | Impute as 7 days per patch plus 7 daysb | 13,131 (81.18) | ||
|
|
Analgesic patch - days’ supply not provided | Imputed as 3 days per patchb | 1127 (7.01) | ||
|
|
Days’ supply provided | Days’ supply was used | 599 (5.94) | ||
|
|
Days’ supply not provided | Impute as 7 days per patchb | 865 (5.38) | ||
| Intravaginal contraceptives | |||||
|
|
Days’ supply provided | Days’ supply was used | 1692 (8) | ||
|
|
Days’ supply not provided | Imputed as 30 days per item in packageb | 19,453 (92) | ||
| Implants and vaccines | |||||
|
|
Days’ supply provided | Days’ supply was used | 18,940 (45.2) | ||
|
|
Days’ supply not provided | Imputed as 1 day | 22,979 (54.8) | ||
| Insulin injections | |||||
|
|
Days’ supply provided | Days’ supply was used | 2601 (3.14) | ||
|
|
Days’ supply not provided | Imputed as 60 days per prescriptionb | 80,266 (96.86) | ||
| Others | |||||
|
|
Days’ supply provided | Days’ supply was used | 69,806 (37.47) | ||
|
|
Days’ supply not calculated nor imputed | — | 116,491 (62.52) | ||
aNot available.
bBased on the Summary of Product Characteristics issued by the Estonian Agency of Medicines.
cMedication not shelf-stable for more than 30 days after opening.